NOVEL PYRIMIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS AN ACTIVE INGREDIENT

摘要

The present invention relates to a compound selected from the group consisting of a compound represented by chemical formula 1 for inhibiting the activity of diacylglycerol 0-acyltransferase type 1, and pharmaceutically acceptable salts thereof, and to a pharmaceutical composition including same as an active ingredient. The compound of the present invention may be used as an effective therapeutic agent for treating, without side effects, diseases such as obesity, type II diabetes, dyslipidemia, metabolic syndrome, etc. induced by the activity of DGAT1. In chemical formula 1, A, B, X and R5-7 are the same as those defined in the present specification.